Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 24,164 shares at $24.18 ($585K) on 2023-08-07, disclosed to the SEC on 2023-08-09.
Scheduled sale ($585k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.18 | 11,223 | $271K | 46.4% |
| 2 | $24.18 | 11,223 | $271K | 46.4% |
| 3 | $24.66 | 1,718 | $42K | 7.2% |
| Total | $24.21 avg | 24,164 | $585K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |